IRCT20190119042417N2招募中3 期
Comparison of the effectiveness of rivastigmine and memantine in improving cognitive problems due to electroconvulsive therapy
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Being in the age range of 18-60 years.
- •Being a candidate to receive electroconvulsive therapy.
- •Collaborate to perform Montreal cognitive assessment.
- •Having informed consent to participate in the study.
排除标准
- •History of neurocognitive disorders such as delirium and dementia
- •History of cardiac conductive disorder and arrhythmia
- •History of hepatic, renal, thyroid, and seizure disorders
- •History of sensitivity to rivastigmine and memantine
- •History of electroconvulsive therapy within the the past 6 months
- •Taking calcium channel blockers and cox-inhibitors
研究者
相似试验
招募中
3 期
Effectiveness of Rivastigmine and Donepezil on cognitive disordersIRCT20210819052232N1Esfahan University of Medical Sciences165
招募中
3 期
Evaluation of the effect of rivastigmine on male patients with chronic schizophreniaIRCT20120314009297N8Mazandaran University of Medical Sciences60
招募中
2 期
The Efficacy of Rivastigmine Augementation to Antipsychotic Agents on Positive and Negative Symptoms and Quality of Life in Patients with Chronic SchizophreniaParanoid schizophreniaChronic schizophrenia.F20.0IRCT20190530043769N1Tabriz University of Medical Sciences60
已完成
2 期
Efficacy of rivastigmin in the treatment of major depressive disorderIRCT2017020132236N4Vice chancellor for research, Mazandaran University of Medical Sciences20
已完成
2 期
The effectiveness of Rivastigmine on treatment of Tardive dyskinesiaTardive dyskinesia.Drug-induced dystoniaIRCT2012092910964N1niversity of Social Welfare and Rehabilitation Sciences40